ebook Munafa Stock Market Course + Intraday & FNO calls  

       

543311 announcements Ipl announcements and dividends declared BSE

Ipl Complete list of announcements declared & dividend announcements by Ipl 543311

Ipl 543311 listed on BSE and deals in

Announcements and dividends declared by Ipl 543311

15 equity mutual funds multiply lumpsum investments by 4.3x in 7 years. Are there any included in your portfolio?
An ETMutualFunds analysis reveals that 15 equity mutual funds multiplied lumpsum investments by over 4.3 times in seven years. Small cap and mid cap schemes dominated the performance list, led by Quant Small Cap Fund, which delivered a 7.75x return alongsi
Announcement as on 07 September 2026

RNFI Services gets RBI in-principle nod to operate as payment aggregator
RNFI Services has received in-principle RBI authorisation to operate as a Payment Aggregator-Physical (PA-P), allowing it to expand into offline and in-store payments. The approval adds another regulated payments capability to its existing financial servic
Announcement as on 07 September 2026

Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Cipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s cancer drug Keytruda. Qilu will handle development, approvals, manufacturing and supply, while Cipla USA will commercial
Announcement as on 04 September 2026

Cipla partners with Qilu to license, supply Keytruda biosimilar in US
Drug major Cipla Ltd on Thursday said its wholly owned subsidiary, Invagen Pharmaceuticals Inc, has entered into a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to the cancer drug Keytruda in the United States.
Announcement as on 04 September 2026

AbbVie Reports Positive Phase 3 Results For Etentamig In Multiple Myeloma
(RTTNews) - AbbVie (ABBV) on Thursday announced positive topline results from the Phase 3 CERVINO trial evaluating investigational etentamig in patients with relapsed/refractory multiple myeloma.
Announcement as on 03 September 2026

Announcements by Ipl first page | Next page |

543311 Ipl current price & indicator signals

Moving Averages for Ipl

  • 5Day Average: 136.65
  • 12Day Average: 137.93
  • 20Day Average: 138.75
  • 50Day Average: 147.23
  • 100Day Average: 154.06
  • 150Day Average: 153.14
  • 200Day Average: 157.32

543311 Indicators & signals

Indicator MACD (12,26,9)

137.78, 140.82, -3.24
Indicator MACD is in negative zone

Indicator ADX (14)

49.12, 9.42, 27.6
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 543311 Ipl are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
08 Tue Sep 2026 134.40 134.05 to 136.65 -1.61% 0.71 times
07 Mon Sep 2026 136.60 136.40 to 138.70 -1.05% 1.02 times
04 Fri Sep 2026 138.05 136.50 to 138.80 0.15% 0.69 times
03 Thu Sep 2026 137.85 136.75 to 139.05 1.1% 0.3 times
02 Wed Sep 2026 136.35 135.55 to 139.00 -1.2% 0.49 times
01 Tue Sep 2026 138.00 136.50 to 138.45 0.58% 0.68 times
31 Mon Aug 2026 137.20 136.40 to 138.70 -1.58% 0.55 times
28 Fri Aug 2026 139.40 138.50 to 139.50 1.6% 0.31 times
27 Thu Aug 2026 137.20 137.00 to 141.60 -2.42% 4.56 times
26 Wed Aug 2026 140.60 138.95 to 140.80 0.68% 0.7 times
25 Tue Aug 2026 139.65 139.10 to 142.00 -0.11% 0.72 times
24 Mon Aug 2026 139.80 139.05 to 142.70 -0.07% 0.72 times

Videos related to: 543311 announcements Ipl announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

543311 announcements Ipl announcements and dividends declared BSE

 

Back to top